Barry A L, Gavan T L, Ayers L W, Fuchs P C, Gerlach E H, Thornsberry C
J Clin Microbiol. 1987 Jan;25(1):165-6. doi: 10.1128/jcm.25.1.165-166.1987.
A multilaboratory study was designed to define quality control limits for microdilution susceptibility tests with norfloxacin. The following limits were proposed: for Escherichia coli ATCC 25922, 0.03 to 0.125 micrograms/ml; for Pseudomonas aeruginosa ATCC 27853, 1.0 to 4.0 micrograms/ml; for Staphylococcus aureus ATCC 29213, 0.5 to 2.0 micrograms/ml; and for Streptococcus faecalis ATCC 29212, 2.0 to 8.0 micrograms/ml. The latter represents a change in the previously recommended control limits.
一项多实验室研究旨在确定诺氟沙星微量稀释药敏试验的质量控制限度。提出了以下限度：对于大肠埃希菌ATCC 25922，为0.03至0.125微克/毫升；对于铜绿假单胞菌ATCC 27853，为1.0至4.0微克/毫升；对于金黄色葡萄球菌ATCC 29213，为0.5至2.0微克/毫升；对于粪肠球菌ATCC 29212，为2.0至8.0微克/毫升。后者代表了先前推荐的控制限度的变化。
